Post Mortem Tissue Donation for Pediatric Cancer Research
This study is collecting tissue from children with cancer and non-cancerous tumors after they have passed away. This is an observational study, meaning researchers are collecting information without giving any new treatments. The goal is to use these donated tissues to create new models in the lab, like mouse models and cell cultures, to better understand pediatric cancers. These models will help researchers study the diseases and test new drugs in the future. To join, families must provide signed consent for post-mortem tissue donation and autopsy. The study aims to successfully collect these tissues for up to 5 years from the time of donation. The current recruitment status is unclear.
- Study design
- This is an observational study planning to enroll 150 participants. It is not testing a new drug or treatment.
- What's involved
- Participants would have their post-mortem tissue collected during an autopsy after consent is obtained.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary goal is the procurement of tissue, measured for up to 5 years from procurement.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Angela Waanders, MD · PRINCIPAL_INVESTIGATOR · Ann & Robert H Lurie Children's Hospital of Chicago
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Procurement of pediatric cancer and non-cancer tumor tissue during autopsy with signed consentUp to 5 years from procurement
Procurement of pediatric cancer and non-cancer tumor tissue during autopsy with signed consent. Tissue will be collected through a research tissue collection autopsy of the original tumor and other sites that are appropriate. Samples of both tumor and normal cells will be collected in addition to body fluids such as cerebrospinal fluid (CSF), blood, bone marrow, and skin biopsies for genomic testing.